Aarti Pharmalabs informs about analyst meet

18 Jun 2025 Evaluate

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, Aarti Pharmalabs has informed that it enclosed schedule for the Analyst / Institutional Investor Meetings. Additionally, no unpublished price sensitive information relating to the Company will be disclosed during these interactions with Analysts/Institutional Investors.

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

777.60 -5.75 (-0.73%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×